NLS Pharmaceutics Ltd. Quarterly Contract with Customer, Liability, Noncurrent in USD from Q4 2023 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.
Summary
NLS Pharmaceutics Ltd. quarterly Contract with Customer, Liability, Noncurrent history and growth rate from Q4 2023 to Q2 2024.
  • NLS Pharmaceutics Ltd. Contract with Customer, Liability, Noncurrent for the quarter ending June 30, 2024 was $2.5M.
Contract with Customer, Liability, Noncurrent, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $2.5M Jun 30, 2024 6-K 2024-10-18
Q4 2023 $2.5M Dec 31, 2023 6-K 2024-10-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.